Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
54.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
7.2% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
25.3% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Indegene
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Digital Transformation And AI Adoption Will Expand Pharma Market
Key Takeaways AI-driven digital solutions and deeper multi-year client relationships are expanding Indegene's market presence, improving revenue growth and operational efficiencies in pharma services. Strategic reinvestment and targeted acquisitions are shifting revenues toward higher-margin, technology-led offerings and expanding capabilities across new verticals and geographies.
View narrative
₹644.67
FV
12.8% undervalued
intrinsic discount
12.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
11 days ago
author updated this narrative
Remitly Global
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Digital Wallets And Stablecoins Will Expand Remittance Markets
Key Takeaways Expansion into digital memberships, wallets, and stablecoins boosts global reach, revenue diversity, and customer loyalty amid rising cross-border and digital financial activity. AI integration and industry trends toward formalization and regulation lower costs, improve margins, and accelerate Remitly's shift from cash to digital leadership.
View narrative
US$28.60
FV
34.5% undervalued
intrinsic discount
20.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
11 days ago
author updated this narrative
Biofrontera
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Label Expansion And New Trials Will Fuel US Dermatology Demand
Key Takeaways Expansion of Ameluz indications, improved reimbursement, and patent extension are set to drive revenue growth and strengthen market position amid rising skin cancer rates. Reduced costs due to lower royalties and focus on new dermatological indications are expected to improve margins and enable future product launches.
View narrative
US$6.38
FV
85.5% undervalued
intrinsic discount
21.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
11 days ago
author updated this narrative
Grove Collaborative Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Shopify Transition And Third Party Expansion Will Improve Efficiency
Key Takeaways Transition to Shopify and strategic acquisitions could enhance operational performance, expand wellness offerings, and positively impact revenue and margins. Shift to direct-to-consumer channels and exit from physical retail are expected to improve margins and drive sustainable growth.
View narrative
US$1.50
FV
3.3% overvalued
intrinsic discount
5.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
15 days ago
author updated this narrative
Verbio
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Global Decarbonization Targets And US Production Will Create Market Tailwinds
Key Takeaways Tightening biofuel supply, favorable policy shifts, and global decarbonization targets are driving demand and price improvements, supporting Verbio’s revenue growth and pricing power. Strategic cost control, technology-driven efficiency gains, and expansion into specialty chemicals and high-value renewables are set to materially lift margins and strengthen the balance sheet.
View narrative
€14.52
FV
28.4% undervalued
intrinsic discount
13.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
11 days ago
author updated this narrative
Harrow
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Rising Specialty Ophthalmics And Biosimilars Will Open New Markets
Key Takeaways Accelerating demand for Harrow's specialty eye drugs and expansion into new treatment areas support strong, sustained top-line and margin growth. Improved patient access, partnerships, and integration of new innovative products strengthen competitive positioning and enable outsized earnings growth.
View narrative
US$59.78
FV
37.5% undervalued
intrinsic discount
38.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
11 days ago
author updated this narrative
Alvotech
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Pipeline Approvals And Global Rollout Will Boost Biosimilar Markets
Key Takeaways Accelerating global biosimilar adoption and strategic partnerships expand Alvotech's market reach, boosting future revenue stability and margin potential. Vertical integration and acquisitions improve operational efficiency and resilience, supporting sustainable earnings growth amid industry-wide cost pressures.
View narrative
US$17.50
FV
52.5% undervalued
intrinsic discount
36.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
11 days ago
author updated this narrative
New York Mortgage Trust
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Business Purpose Lending Will Unlock Affordable Housing Demand
Key Takeaways Direct control of loan origination and portfolio diversification enhance revenue stability, risk-adjusted returns, and positioning in growing rental and affordable housing markets. Improved liquidity, lower financing costs, and scalable origination capability support margin expansion, efficient capital deployment, and long-term earnings growth.
View narrative
US$10.46
FV
32.1% undervalued
intrinsic discount
0.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
19
users have followed this narrative
11 days ago
author updated this narrative
Salzgitter
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
European Measures And Green Steel Will Forge Resilient Future
Key Takeaways EU carbon regulations and government infrastructure spending are set to tighten steel supply and boost demand in Salzgitter's key markets, supporting future growth. Green steel initiatives, cost optimization, and expanded vertical integration are expected to increase margins, profitability, and earnings stability.
View narrative
€22.77
FV
0.4% overvalued
intrinsic discount
2.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
11 days ago
author updated this narrative
Value any company in seconds
Popular companies